Medicine & Life Sciences
Burkitt Lymphoma
100%
Nuclear Pore
83%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
83%
Oncogenes
80%
Aryl Hydrocarbon Receptors
79%
Neoplasms
72%
DNA Methylation
61%
Serine
60%
Natural Killer Cells
57%
Lymphoma
51%
Carcinogenesis
47%
T-Lymphocytes
46%
Euchromatin
45%
Peptidylprolyl Isomerase
44%
Maintenance
43%
Phosphorylation
42%
Gene Expression
37%
Proline
33%
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
32%
Genes
25%
Interferon Type I
24%
DNA
24%
Renal Cell Carcinoma
23%
DNA methyltransferase 3B
21%
Down-Regulation
17%
Genome
16%
Chromatin Immunoprecipitation
13%
Adenocarcinoma of Lung
13%
Transcription Factors
13%
Tetracycline
13%
Ribosomes
12%
B-Cell Lymphoma
12%
Up-Regulation
12%
Transgenes
12%
Carcinogens
12%
Adoptive Transfer
11%
Transgenic Mice
11%
Epigenomics
10%
Small Interfering RNA
10%
Hepatocellular Carcinoma
10%
Cell- and Tissue-Based Therapy
9%
9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine
9%
Cell Proliferation
8%
Spleen
8%
Growth
7%
Cell Count
7%
Phenotype
7%
Cell Line
7%
Ligands
7%
Physics & Astronomy
surveillance
78%
switches
50%
interferon
36%
cells
33%
mice
32%
oncogenes
18%
effectors
15%
leukemias
14%
spleen
14%
secretions
14%
deactivation
11%
therapy
9%
perturbation
6%